BVMF/C1IC34 (BVMF/C1IC34)

Brazil Stock Exchange: BVMF/C1IC34 · BRL

R$66.6

+2.66 (+4.2%)· Recorded snapshot

Market cap	421.4B
Revenue (ttm)	1.5T
Net income (ttm)	33.2B
EPS (ttm)	R$5.41
P/E (trailing)	12.3x
P/E (forward)	9.5x
Dividend	R$0.90 (1.35%)
Volume	18
Beta	0.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5T
Net income (ttm): 33.2B
EPS (ttm): R$5.41
P/E (trailing): 12.3x
P/E (forward): 9.5x
Market cap: 421.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E9.5

P25 n/aP50 n/aP75 n/a

Trailing P/E12.3

P25 n/aP50 n/aP75 n/a

ROE16.8

P25 n/aP50 n/aP75 n/a

ROIC13.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/C1IC34 indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-05
Employees	67,700
Employees change	-5,800
Employees growth	-7.89%
Enterprise value	BRL 554.6B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1792
Industry	Healthcare Plans
Is primary listing	No
ISIN number	BRC1ICBDR000
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	2026-08-10
Last stock split type	Forward
Market cap	BRL 421.4B
Next earnings date	2026-11-05
Price	BRL 66.57
Price currency	BRL
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-27
Symbol	bvmf/C1IC34
Website	https://www.thecignagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	16.32x
Average P/E ratio (3Y)	18.63x
Average P/E ratio (5Y)	16.34x
Earnings yield	8.12%
EV/Earnings	16.69x
EV/EBIT	9.41x
EV/EBITDA	8.13x
EV/FCF	11.75x
EV/Sales	0.37x
FCF / EV yield	8.51%
FCF yield	11.2%
Forward P/E	9.46x
Graham number	64.40868
Graham upside	-3.25%
Lynch fair value	BRL 26.25
Lynch upside	-60.56%
P/B ratio	1.9x
P/E ratio	12.31x
P/FCF ratio	8.93x
P/OCF ratio	7.92x
P/S ratio	0.29x
Price/EBITDA ratio	6.38x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	3.9%
EBITDA margin	4.52%
Effective tax rate	19.17%
FCF margin	3.12%
Gross margin	9.14%
Operating margin	3.9%
Pretax margin	3.06%
Profit margin	2.27%
Profit per employee	BRL 498,463
Profitable quarters	9
Profitable years	23
Revenue per employee	BRL 21.9M
ROA	4.46%
ROA (5Y)	3.74%
ROCE	10.86%
ROE	16.76%
ROE (5Y)	12.28%
ROIC	13.39%
ROIC (5Y)	10.87%
Tax / revenue	0.59%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	32.61%
EPS growth (Q)	10.16%
EPS growth (QoQ)	0.48%
EPS growth 10Y	12.11%
EPS growth 3Y	3.06%
EPS growth 5Y	1.12%
EPS growth quarters	2
EPS growth years	1
FCF growth	131.06%
FCF growth 3Y	-7.23%
FCF growth 5Y	13.14%
Gross profit growth	-0.13%
Gross profit growth (Q)	6.07%
Gross profit growth 3Y	3.06%
Gross profit growth 5Y	2.25%
Net income growth	27.86%
Net income growth (Q)	8.36%
Net income growth (QoQ)	0.36%
Net income growth 3Y	-1.32%
Net income growth 5Y	-4.67%
Net income growth quarters	2
Net income growth years	1
OCF growth	94.2%
OCF growth 10Y	13.04%
OCF growth 3Y	-7.3%
OCF growth 5Y	11.42%
Operating income growth	12.72%
Operating income growth (Q)	15.72%
Operating income growth 3Y	10.7%
Operating income growth 5Y	7.44%
Revenue growth	7.77%
Revenue growth (Q)	6.68%
Revenue growth (QoQ)	4.63%
Revenue growth 10Y	21.97%
Revenue growth 3Y	14.9%
Revenue growth 5Y	11.11%
Revenue growth quarters	66
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -6B
Depreciation and amortization	BRL 9.3B
EBIT	BRL 57.1B
EBITDA	BRL 66.1B
EPS	BRL 5.41
Financing cash flow	BRL -12.1B
Free cash flow	BRL 47.2B
Gross profit	BRL 133.7B
Income taxes	BRL 8.6B
Investing cash flow	BRL -30.8B
Net borrowing	BRL 5.7B
Net cash flow	BRL 10.2B
Net income	BRL 33.2B
Operating income	BRL 57.1B
Revenue	BRL 1.5T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.81
Book value per share	BRL 837.34
Debt / EBITDA	2.5
Debt / equity	0.74
Debt / FCF	3.5
Goodwill	BRL 244.3B
Interest coverage	7.78
Long-term assets	BRL 561.7B
Long-term liabilities	BRL 293.4B
Net cash (debt)	BRL -127.6B
Net cash / market cap	-30.27%
Net debt / EBITDA	1.93
Net debt / equity	0.57
Net debt / FCF	2.7
Piotroski F-Score	6
Property, plant and equipment	BRL 20B
Shareholders' equity	BRL 222.3B
Tangible book value	BRL -154.6B
Tangible book value per share	BRL -586.35
Total assets	BRL 813.8B
Total cash	BRL 37.6B
Total debt	BRL 165.2B
Total liabilities	BRL 591.5B
WACC	5.24%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.83
Current assets	BRL 252.1B
Current liabilities	BRL 298.1B
Current ratio	0.85
Inventory turnover	43.44
Net working capital	BRL -67.5B
Quick ratio	0.69
Working capital	BRL -44.4B
Working capital turnover	-141.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.55%
Dividend growth	8.66%
Dividend growth (3Y)	9.85%
Dividend growth (5Y)	16.11%
Dividend growth years	5
Dividend payment date	2026-09-29
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.90
Dividend yield	1.35%
Ex-dividend date	2026-09-04
Last dividend	BRL 0.04
Payout ratio	25.31%
Shareholder yield	4.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 65.75
1D price change	4.16%
1M price change	13.93%
1M total return	13.93%
1W price change	9.31%
1W total return	9.31%
1Y price change	-2.16%
1Y return CAGR	-0.7%
1Y total return	-0.7%
20-day SMA	BRL 60.97
200-day SMA	BRL 65.00
3M price change	10.51%
3M total return	10.89%
3Y price change	4.8%
3Y return CAGR	2.91%
3Y total return	8.98%
50-day SMA	BRL 60.05
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 68.82
52-week high date	2026-10-26
52-week low	BRL 53.33
52-week low date	2026-03-04
5Y price change	33.41%
5Y return CAGR	7.27%
5Y total return	42.05%
6M price change	15.14%
6M total return	15.97%
All-time high	BRL 85.10
All-time high date	2024-11-29
All-time low	BRL 33.93
All-time low date	2020-03-13
Average true range (ATR)	BRL 1.98
Average volume	111
Beta (5Y)	0.3
Change from 52-week high	-3.27%
Change from 52-week low	24.82%
Change from all-time high	-21.77%
Change from all-time low	96.18%
Change from open	-0.94%
Day's gap	5.15%
Dollar volume	BRL 1,198
High price	BRL 67.20
Low price	BRL 66.44
Monthly RSI	52.61
Open price	BRL 67.20
Position in 52-week range	17.11%
Previous close	BRL 63.91
Price vs 150-day SMA	1.25%
Price vs 20-day SMA	9.18%
Price vs 200-day SMA	2.42%
Price vs 50-day SMA	10.87%
Relative volume	0.16
RSI	60.96
Sharpe ratio	0.58
Sortino ratio	0.96
Volume	18
Weekly RSI	56.36
YTD price change	3.65%
YTD total return	4.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	262.9M
Shares change (QoQ)	-0.02%
Shares change (YoY)	-3.55%
Shares held by insiders	0.38%
Shares held by institutions	92.59%
Short ratio	4.1 days

Deeper analysis on BVMF/C1IC34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/C1IC34 report

Is a complete BVMF/C1IC34 research report available?

No complete published report is available for bvmf/C1IC34 (BVMF/C1IC34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/C1IC34 (BVMF/C1IC34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/C1IC34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/C1IC34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/C1IC34

Frequently asked questions